Clínica e Investigación en Arteriosclerosis

LDL como objetivo terapéutico Ángel Díaz Rodríguez; Teresa Mantilla Morató;

First real-world experience with inclisiran in Spain: Efficacy, safety, and prescription patterns in clinical practice Alvaro Velasco; Ramón Costa; Jesús Alonso-Carrillo; Marta de Castro; Cristina Hayes Meizoso; Agustín Blanco-Echevarria; Rocío Tello; Jorge Solís;

Inclisiran for LDL-C reduction in secondary prevention: Real-world evidence from a homogeneous Spanish cohort with subgroup insights Victoria Piro; Elena Fuente; Francisco Romano; Mario Galván; Miguel Fernández; María del Val Groba; Marta López; Antonio García;